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Actin-based remodeling underlines spine morphogenesis and plasticity and is crucially
involved in the processes that constantly reshape the circuitry of the adult brain in
response to external stimuli, leading to learning and memory formation and supporting
cognitive functions. Hence spine morphology and synaptic strength are tightly linked and
indeed abnormalities in spine number and morphology have been described in a number
of neurological disorders such as autism spectrum disorders (ASDs), schizophrenia
and intellectual disabilities. We have recently demonstrated that the actin regulating
protein, Epidermal growth factor receptor pathway substrate 8 (Eps8), is essential for
spine growth and long term potentiation. Indeed, mice lacking Eps8 display immature
filopodia-like spines, which are unable to undergo potentiation, and are impaired in
cognitive functions. Furthermore, reduced levels of Eps8 have been found in the brain
of a cohort of patients affected by ASD compared to controls. Here we investigated
whether the lack of Eps8, which is also part of the N-methyl-d-aspartate (NMDA)
receptor complex, affects the functional maturation of the postsynaptic compartment.
Our results demonstrate that Eps8 knock out mice (Eps8 KO) neurons display altered
synaptic expression and subunit composition of NMDA receptors (i.e., increased
GluN2B-, decreased GluN2A-containing receptors) and impaired GluN2B to GluN2A
subunit shift. Indeed Eps8 KO neurons display increased content of GluN2B containing
NMDA receptors both at the synaptic and extrasynaptic level. Furthermore, Eps8 KO
neurons display an increased content of extra-synaptic GluN2B-containing receptors,
suggesting that also the synaptic targeting of NMDA receptors is affected by the lack
of Eps8. These data demonstrate that, besides regulation of spine morphogenesis,
Eps8 also regulates the synaptic balance of NMDA receptors subunits GluN2A and
GluN2B.
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INTRODUCTION
Filamentous actin (F-actin) represents the major cytoskeletal
component of dendritic spines (Fifková and Delay, 1982; Cohen
et al., 1985), controlling spine shape, size and number through
local, rapid changes in its dynamics (Matus et al., 1981; Fischer
et al., 1998). Actin is highly enriched at the postsynaptic
density (PSD) where, through the interaction with a cohort of
scaffolding proteins (Qualmann et al., 2004), it anchors receptors,
thus acting as a key determinant of synaptic strength (Sheng
and Hoogenraad, 2007). Accordingly, F-actin depolymerization
disperses α-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA) and N-methyl-d-aspartate (NMDA) receptors at
excitatory synapses and reduces the clusters of gephyrin, a glycine
receptor scaffolding protein, at inhibitory synapses (Allison
et al., 1998; Hanley, 2014). Actin cytoskeleton also regulates
postsynaptic receptor mobility in and out of synapses. As an
example, in the case of glycine receptors, disruption of F-actin
enhances the rate of exchange of synaptic and extrasynaptic
receptors, while decreasing receptor ‘‘dwell’’ time at synapses
and increasing the diffusion of receptor subsets within synapses
(Charrier et al., 2006; Dumoulin et al., 2009). Therefore, rather
than being a ‘‘molecular glue,’’ actin appears to crucially
contribute to the differential organization of distinct pools of
receptors promoting the potential sub-cluster associations within
the postsynaptic specialization. A similar function for actin
might extend to excitatory synapses, that harbor AMPA-type
and NMDA-type glutamate receptors, which are differentially
sensitive to actin depolymerization (reviewed in Cingolani and
Goda, 2008).
NMDA receptors (thereafter referred as NMDARs) are
hetero-tetramers comprising numerous combinations of
GluN1 and GluN2A-D subunits, which serve for the binding to
co-agonist or to glutamate respectively (see for a review Paoletti
et al., 2013). Many of the unique properties of NMDARs have
been invariably attributed to the diversity of the individual
subunits and their combinations to form the receptor (Wyllie
et al., 2013). NMDAR composition is developmentally regulated:
GluN2B subunits are highly expressed during early development
and reach a peak around the second postnatal week, whereas
GluN2A subunit levels increase only after birth, exceeding
GluN2B subunits by adulthood (Monyer et al., 1994; Barth
and Malenka, 2001). The progressive increase of GluN2A
at developing synapses is essential for synaptic maturation,
and mature neuronal network establishment (Yashiro and
Philpot, 2008). NMDARs, both GluN1 and GluN2 subunits, are
immediately associated with the cytoskeleton via protein–protein
interactions with F-actin (Wyszynski et al., 1997; Wechsler and
Teichberg, 1998). The integrity of the cytoskeleton influences the
activity of NMDARs (Rosenmund and Westbrook, 1993) and,
in turn, activation of NMDARs can trigger depolymerization
of actin (Sattler et al., 2000). Actin dynamics are controlled by
ensembles of actin-binding proteins (Konietzny et al., 2017).
These proteins play different functional roles in regulating
actin dynamics, including binding and/or sequestering of
actin monomers, nucleation of actin filaments, capping or
anti-capping of barbed ends, and severing, bundling and
anchoring of F-actin (Nicholson-Dykstra et al., 2005; Pak
et al., 2008; Shekhar et al., 2016). In particular actin capping
proteins regulate actin polymerization and dynamics by binding
the barbed end of an actin filament and blocking addition
and loss of actin subunits (Edwards et al., 2014). Hence
actin capping proteins play a key role in maintaining the
integrity of actin cytoskeleton (Hotulainen and Hoogenraad,
2010).
Epidermal growth factor receptor pathway substrate 8 (Eps8)
is a multi-functional actin-binding protein which participates,
via its SH3 domain, in the formation of distinct macromolecular
complexes that transduce signals from Ras to Rac and control
actin capping and bundling activities (Scita et al., 1999; Disanza
et al., 2004, 2006). During neuronal development, Eps8, by
inhibiting actin elongation, down-regulates axonal filopodia
formation in neurons with Eps8 phosphorylation leading to
inhibition of its actin-capping function and stimulation of
filopodia extension (Menna et al., 2009). Consistently, absence
of Eps8 has been found to alter the growth of vestibular hair cells
stereocilia (Tavazzani et al., 2016).
In mature primary hippocampal neurons, Eps8 is recruited to
the spine head during long-term potentiation promoting spine
head enlargement, which typically occurs during potentiation
processes. Indeed, inhibition of Eps8 actin-capping activity
impairs spine enlargement, leading to an excessive formation
filopodia-like spines which are unable to undergo plasticity
(Menna et al., 2013). Accordingly, mice lacking Eps8 (Eps8 knock
outmice, Eps8 KO) display increased density of immature spines,
which is correlated with a learning and memory impairment
of Eps8 deficient mice (Menna et al., 2013). Furthermore,
Eps8 levels were found to be reduced in the brains of a cohort
of patients affected by autism spectrum disorders (ASDs; Menna
et al., 2013). Eps8 has been found to be expressed in cerebellar
glomeruli, with a pattern of expression typically postsynaptic and
coinciding with that of F-actin. Here, Eps8 was found to interact
with the NMDAR subunits, GluN2A, GluN2C and GluN1, but
not with GluA1 subunit of AMPA-type receptors, indicating
Eps8 as part of the NMDAR complex (Offenhauser et al.,
2006). Eps8 controls granule cell NMDA postsynaptic currents,
with Eps8 KO cerebellar granule neurons displaying increased
current amplitude and slower decay kinetics (Offenhauser et al.,
2006).
Based on these experimental results we investigated whether
Eps8 may control the expression and function of NMDARs
or specific NMDAR subunits. Using Eps8 KO neurons and
brain extracts, we analyzed the GluN2A/2B subunit ratio in
NMDARs and we demonstrate that lack of Eps8 affects NMDAR
expression, synaptic localization and function by increasing the
amount of GluN2B subunits at the synaptic and extra-synaptic
level while amount of synaptic GluN2A-containing receptors is
reduced.
MATERIALS AND METHODS
Cell Cultures
All the experimental procedures followed the guidelines
established by the Italian Council on Animal Care and were
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approved by the Italian Government Decree No. 27/2010
(see Supplementary Information) and the Italian Legislation
(L.D. no. 26/2014). All efforts were made to minimize the
number of animals used and their sufferings. All animals were
housed with 12/12-h light/dark cycle with food and water
available ad libitum. Embryonic (E18) primary cultures of
mouse hippocampal neurons were established from Eps8 KO1
and wild type (WT) mice obtained from breeding settled
up in our animal facility as described by Menna et al.
(2013). Briefly, hippocampi were dissociated by treatment
with trypsin (0.125% for 15 min at 371◦C), followed by
trituration with a polished Pasteur pipette. The dissociated cells
were plated onto glass coverslips coated with poly-L-lysine at
density of 400 cells/mm2. For low density neuronal cultures
used in paired electrophysiological experiments, dissociated
cells were plated onto glass coverslips coated with poly-
L-lysine at density of 150–200 cells/mm2. The cells were
maintained in Neurobasal (Invitrogen) with B27 supplement and
antibiotics, 2 mM glutamine and 12.5 mM glutamate (neuronal
medium).
Subcellular Fractionation
Western blot analysis was performed in hippocampal tissue of
Eps8 KO and WT adult (5 months of age) littermates mice.
To obtain a preparation that contains selectively proteins of
the excitatory PSD, subcellular fractionation was performed
as reported previously with minor modifications (Gardoni
et al., 2001b). Hippocampi were homogenized in 0.32 M
ice-cold sucrose containing the following (in mM): 1 HEPES,
1 MgCl2, 1 EDTA, 1 NaHCO3 and 0.1 PMSF at pH 7.4,
in the presence of a complete set of proteases inhibitors
(Complete; Roche Diagnostics) and phosSTOP Phosphatase
Inhibitor (Roche Diagnostics). The homogenized tissue was
centrifuged at 13,000× g for 10 min (P2 fraction). The pellet
was resuspended in buffer containing 75 mMKCl and 1% Triton
X-100 and centrifuged at 100,000× g for 1 h. The supernatant was
stored and referred as Triton X-100-soluble fraction (TSF). The
final pellet (triton insoluble fractions, TIF) was homogenized in
a glass–glass potter in 20 mM HEPES. TIF was used instead of
the classical PSD because the amount of the starting material was
very limited. The protein composition of this preparation was,
however, carefully tested for the absence of presynaptic markers
(i.e., synaptophysin; Gardoni et al., 2009). Similar protein yield
was obtained in TIF purified from hippocampal tissue of all
experimental groups.
Western Blot (WB)
WB analysis was performed in homogenate and TIF
fractions. Protein samples were separated onto an
acrylamide/bisacrylamide gel at the appropriate concentration
and transferred to a nitrocellulose membrane. Nitrocellulose
articles were blocked with 10% albumin in tris-buffered
saline (TBS) and then incubated overnight at 4◦ with the
primary antibodies. After extensive rinsing in TBS/0.1%
Tween 20, the nitrocellulose articles were then incubated
1http://www.informatics.jax.org/allele/MGI:3693626
with horseradish peroxidase-conjugated secondary antibodies
(goat anti-rabbit, for polyclonal antibodies, diluted 1:10,000
(Pierce); goat anti-mouse, for monoclonal antibodies, diluted
1:10,000 (Pierce). Membrane development was performed
with the reagent Clarity Western ECL Substrate (Bio-Rad) or
LiteAblot TURBO (Euroclone) and labeling was visualized by
Chemidoc Imaging System and ImageLab software (Bio-Rad).
For quantification, each protein was normalized against the
corresponding tubulin band. The following unconjugated
primary antibodies were used: GluN2A (diluted 1:1,000; Sigma-
Aldrich M264), GluN2B (diluted 1:1,000; Neuromab 75–101),
PSD-95 (diluted 1:2,000; Neuromab 75–028), tubulin (diluted
1:10,000; Sigma-Aldrich T9026), Phospho-p44/42 MAPK
(Erk1/2; Thr202/Tyr204; diluted 1:2,000; Cell signaling 9101),
p44/42 MAPK (Erk1/2; diluted 1:2,000; Cell signaling 9102),
total GluN2B (Mellone et al., 2015) p1472 (diluted 1:1,000;
Calbiochem 454583).
Surface Staining for GluN2B
Living neurons were incubated for 10 min with rabbit
antibodies directed against extracellular epitopes of GluN2B
(diluted 1:100, Alomone Labs AGC-003), washed and fixed
with 4% paraformaldehyde and 4% sucrose as described
(Joshi et al., 2017). The guinea pig anti-Bassoon (diluted
1:500, Synaptic System 141004) was used to double stain
the cultures. Secondary antibodies were conjugated with
Alexa-488 and Alexa-555 (Alexa-Invitrogen). Images were
acquired using a Zeiss LSM800 confocal microscope equipped
with a Plan-Apochromat 63×/1.40 oil objective. Acquisition
parameters (i.e., laser power, gain and offset) were kept constant
among different experimental settings. Surface synaptic GluN2B
staining was quantified as follows. GluN2B-, bassoon-positive
puncta and GluN2B puncta colocalizing with bassoon (both
number and size) were measured using ImageJ 1.46r software
in GluN2B and bassoon confocal images after setting a fixed
threshold using the ‘‘analyze particle’’ and ‘‘image processing’’
functions. The ‘‘synaptic surface GluN2B’’ is calculated by the
ratio of the ‘‘area of surface GluN2B colocalizing with bsn/area
of surface GluN2B.’’ Approximately 10–15 fields were acquired
per independent experiments. All data are results of at least three
independent experiments.
For the staining of F actin, vehicle- and Latrunculin B (LatB)-
treated cultures were fixed with 4% paraformaldehyde and
4% sucrose as described (Bedogni et al., 2016). AlexaFluor555
conjugated–phalloidin (diluted 1:200, Molecular Probes A34055)
and the mouse monoclonal PSD-95 (diluted 1:400, Neuromab
75–028) were used.
Cell Culture Electrophysiology
Whole cell voltage-clamp recordings were performed on WT
and transgenic E18 hippocampal neurons maintained in culture
for 13–15 DIV. During recordings cells were bathed in a
standard external solution containing (in mM): 125 NaCl,
5 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2 CaCl2, 6 glucose and
25 HEPES-NaOH, pH 7.4. Recording pipettes were fabricated
from borosilicate glass capillary using an horizontal puller (Sutter
Instruments) inducing tip resistances of 3–5 M and filled with
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a standard intracellular solution containing (in mM): 130 Cs-
gluconate, 8 CsCl, 2 NaCl, 4 EGTA, 10 HEPES-NaOH, 2 MgCl2,
4 MgATP and 0.3 Tris-GTP.
For miniature AMPA-NMDA EPSC recordings, cells were
bathed in a free Mg2+ solution containing (in mM) 125 NaCl,
5 KCl, 1.2 KH2PO4, 2 CaCl2, 6 glucose and 25 HEPES-NaOH,
tetrodotoxin (TTX) 0.001, Strychnine 0.001 and bicuculline
methiodide 0.02, glycine 0.01 (pH 7.4; Tocris). To record the
pure NMDA currents 6-cyano-7-dinitroquinoxaline-2,3-dione
(CNQX) 20 µM (Tocris) were added to standard extracellular
solution to block the AMPA component of the current. The
patch pipette electrode contained the following (in mM):
130 CsGluconate, 8 CsCl, 2 NaCl, 10 HEPES, 4 EGTA, 4 MgATP
and 0.3 Tris-GTP.
AMPA and NMDA evoked currents were recorded in isolated
pairs of neurons in low-density cultures. Neurons were bathed
in a standard external solution containing (in mM): 125 NaCl,
5 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2 CaCl2, 6 glucose and
25 HEPES-NaOH, pH 7.4. Neurons were held at −70 mV or
at +40 and eEPSC evoked by a 100-mV depolarization pulse
in the presynaptic cell lasting 1 ms. The AMPA/NMDA ratio
was calculated by estimating the respective AMPA and NMDAR
current on the traces at +40 mV based on their different time
courses (NMDA component was calculated 40 ms after stimulus
artifact).
For whole-cell total currents recording were bathed in a
free Mg2+ solution containing (in mM) 125 NaCl, 5 KCl,
1.2 KH2PO4, 2 CaCl2, 6 glucose and 25 HEPES-NaOH, TTX
0.001, Strychnine 0.001 and bicuculline methiodide 0.02, glycine
0.01 (pH 7.4). NMDA whole-cell total currents were elicited
by fast local application of saturating NMDA concentrations,
which activate both synaptic and extrasynaptic receptors.
NMDA (200 µM) will be applied with or without inhibitors
(ifenprodil 3 µM or Zinc 10 nM in zinc-free tricine solution
to block GluN2B and GluN2A respectively; Paoletti et al.,
1997).
To measure rectification, spontaneous AMPA-mediated
currents were measured at−60 and at +50 mV, under conditions
in which spontaneous AMPA currents could be isolated. For
these experiments the ACSF contained 0.01 µM TTX (to raise
spike threshold), APV (100 µM) and MK801 (50 µM) to block
NMDA currents, and bicuculline (20 µM) to block inhibitory
potentials. The internal solution contained spermine (120 µM)
was Cs-based to facilitate voltage-clamping at +50 mV. To
compute the rectification index the average peak amplitude at
+50 was divided by the average peak amplitude at −60; the
smaller this value, the more rectification. To induce synaptic
scaling, neurons were treated with 1 µM TTX for 48 h and then
mEPSC currents were recorded.
For the analysis of the tonic, inward, noisy current recordings
were carried out in [0 Mg2+]e, 20 µM CNQX, bicuculline
(50 µM) and TTX (1 µM), before and after blocking NMDAR
function with APV (50 µM) or ifenprodil (3 µM). Two
alternative approaches were used to quantify tonic NMDAR
current. First, it was assessed as the shift in holding current
resulting from NMDA blocker (AP5) application, second,
AP-5-associated change in a baseline noise. Quantification of
background noise was obtained plotting all values of recordings
traces and comparing the fluctuation of values distribution.
Recordings were performed at room temperature in voltage
clamp mode using a Multiclamp 700B amplifier (Molecular
Devices) and pClamp-10 software (Axon Instruments). Series
resistance ranged from 10 M to 20 M and was monitored
for consistency during recordings. Cells in culture with leak
currents >100 pA were excluded from the analysis. Signals were
amplified, sampled at 10 kHz, filtered to 2 or 3 KHz and analyzed
using pClamp 10 data acquisition and analysis program.
Statistical Analysis
Statistical analysis was performed using Prism6 (GraphPad),
data are presented as mean ± SEM from the indicated number
of experiments. After testing whether data were normally
distributed or not, the appropriate statistical test, followed by
specific multiple comparison post hoc tests, has been used as
indicated in figure legends. Kolmogorov–Smirnov test was used
to determine significance in cumulative distributions of mEPSC
amplitudes. Differences were considered to be significant if
P < 0.05 and are indicated by one asterisk; those at P < 0.01 are
indicated by double asterisks; those at P < 0.001 are indicated
by triple asterisks, those at P < 0.0001 are indicated by four
asterisks.
RESULTS
Eps8 KO Neurons Display Reduced
NMDA-Mediated Synaptic Activity
To test whether the lack of Eps8 affects NMDAR function,
NMDA-mediated miniature excitatory currents (mEPSCs) were
recorded in mature WT and Eps8 KO primary hippocampal
neurons (DIV 14–15) in Mg2+ free solution in the presence
of TTX (1 µM) to block action potential-mediated release,
the GABA-A receptor antagonist bicuculline (20 µM)
and the selective antagonist of AMPA/kainate glutamate
receptors CNQX (20 µM). A significantly lower frequency of
NMDA-mediated mEPSCs was recorded in mutant neurons
compared to WT (Hz, WT = 2.153 ± 0.162, n = 11 cells;
EPS8 KO = 1.491 ± 0.218, n = 17 cells, Unpaired t-test
∗P = 0.0374 data are expressed and mean± SEM; Figures 1A,B),
suggesting a reduced NMDA synaptic component in mature
Eps8 KO hippocampal cultures.
In line with a reduced NMDA synaptic component, the
NMDA evoked current appeared to be lower in Eps8 KO neurons
relative to controls. Indeed, temporal separation of AMPA and
NMDA evoked components (obtained by maintaining neurons
in 1.2 mM Mg2+ to block NMDA currents and record the
AMPA component at –70 mV, or by stimulating neurons at
+30mV to record the NMDAR component of the EPSC) revealed
a significant increase of the AMPA/NMDA ratio in Eps8 KO
neurons (WT = 2.7 ± 0.2, n = 9; KO = 4.12 ± 0.3, n = 5; Mann
Whitney test ∗P = 0.0159; Figures 1E–G). On the contrary the
AMPA evoked component, obtained by measuring the EPSC
peak amplitude at −70 mV (see also ‘‘Materials and Methods’’
section), was not changed between WT and Eps8 KO neurons
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FIGURE 1 | Epidermal growth factor receptor pathway substrate 8 (EPS8) deficiency reduces N-methyl-d-aspartate (NMDA)-mediated synaptic activity.
(A) Representative traces of NMDA receptor-mediated mEPSCs (NMDA-mEPSC) recorded from mature wild type (WT) and Eps8 knock out mice (Eps8 KO) primary
hippocampal neurons. Scale bars 10 pA, 50 ms. (B–D) Quantitation of mEPSC frequency, cumulative probability plot of mEPSC amplitudes and decay time showing
a reduced frequency (Unpaired t-test, ∗P = 0.0374) and an increased amplitudes (Kolmogorov-Smirnov test, ∗ = 0.0348, D = 0.4500) and decay time (Unpaired
t-test, ∗∗P = 0.001) in Eps8 KO with respect to wt neurons. (E) Graphical scheme to show the difference in time course of α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA) and NMDA currents. The AMPA component was obtained by measuring the EPSC peak amplitude at −70 mV; the NMDA component was
determined by measuring the current amplitude at 100 ms after EPSC onset at +40 mV (vertical line). (F) Examples of evoked EPSCs composed of AMPAR and
NMDAR-mediated components recorded in WT and EPS8 KO hippocampal neurons. Scale bars 20 pA, 5 s. (G) AMPA/NMDA ratio analysis showing a statistically
significant increase of AMPA/NMDA ratio in Eps8 KO neurons (data are shown as mean ± SEM; Mann Whitney test ∗P = 0.0159).
(pA, WT = 37.2 ± 11, n = 9; KO = 35.4 ± 5.5, n = 6; Mann
Whitney test P = 0.9).
Notably, Eps8 KO miniature NMDA currents
displayed a larger amplitude and a slower decay time
(pA: WT = 8.527 ± 0.3878; EPS8 KO = 10.7 ± 0.7462;
data shown as cumulative probability, Kolmogorov-Smirnov
test, ∗ = 0.0348, D = 0.4500. Decay time, ms: WT = 94.8 ± 4;
EPS8 KO= 125± 6; Unpaired t-test ∗∗P = 0.0010; Figures 1C,D).
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FIGURE 2 | Increased GluN2B and reduced GluN2A synaptic content of NMDARs in Eps8 KO neurons. (A) Representative traces of NMDAR mediated mEPSCs
recorded from WT and EPS8 KO hippocampal neurons in the presence or not of the GluN1/GluN2B blocker Ifenprodil (3 µM). Scale bar 10 pA, 50 ms. (B,C)
Quantification of the inhibitory effect of ifenprodil on the NMDA-mEPSC frequency and amplitude respectively showing increased inhibition in KO neurons with
respect to WT (B: Mann Whitney Test ∗P = 0.0270; C: Unpaired t test ∗∗P = 0.0065). (D) Examples of whole-cell currents elicited in WT and EPS8 KO hippocampal
neurons by application of a saturating concentration of NMDA (200 µm) in the presence or absence of GluN2B-selective antagonist ifenprodil (3 µM). Scale bar
300 pA, 2 s. Quantitation of current density (E), %age of ifenprodil inhibition (F) showing a larger amount of ifenprodil-dependent inhibition in KO neurons with
respect to WT (Mann Whitney Test ∗P = 0.0127). (G) Summary distribution graph of whole-cell currents elicited in WT and EPS8 KO treated or not with tricine
(10 mM) showing a reduced GluN2A-dependent increase of current density upon tricine exposure in KO neurons with respect to WT (Mann Whitney Test,
∗∗∗P <0.001 and ∗P = 0.0220). (H) Representative traces of whole-cell currents elicited in Vehicle and Latrunculin B (LatB)-treated neurons by application of
(Continued)
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FIGURE 2 | Continued
a saturating concentration of NMDA (200 µm) in the presence or absence of
GluN2B-selective antagonist ifenprodil (3 µM). Scale bar 500 pA, 2 s
Quantitation of current density (I), %age of ifenprodil inhibition (J) showing a
larger amount of ifenprodil-dependent inhibition in LatB-treated neurons with
respect to vehicle treated neurons (Unpaired t-test ∗∗P = 0.0078). (K) Images
of neurons live stained for GluN2B (red), fixed and counterstained against the
presynaptic marker bassoon (green). Scale bar depicts 10 µm for the low
magnification image and 3 µm for the higher magnification image. (L) The dot
blot distribution graph shows quantification of the surface synaptic GluN2B
signal (i.e., area of GluN2B puncta colocalizing with bassoon positive
puncta/total area of GluN2B (data are mean ± SEM, N = 3; Mann-Whitney
Rank Sum Test, ∗∗∗∗P ≤ 0.0001).
Altogether these results indicate that Eps8 KO hippocampal
neurons display reduced NMDAR synaptic activity which is
also characterized by higher amplitude and a slower decay
time, raising the possibility that mutant synapses may be
endowed with different subtypes of NMDAR subunits (Cull-
Candy and Leszkiewicz, 2004; Erreger et al., 2005; Santucci and
Raghavachari, 2008).
Lack of Eps8 Affects the Subunit
Composition of NMDARs
Given that Eps8 KO hippocampal neurons display slower
decay of NMDA current (Figure 1D), we assessed the
possible occurrence of GluN2-related differences in NMDAR
stoichiometry at the mutant and WT synapses. To probe the
subunit composition for GluN2B and GluN2A, we tested the
effect of ifenprodil, a GluN2B subunit-specific antagonist of
NMDARs (Tovar and Westbrook, 1999; Cull-Candy et al.,
2001), in 14–15 DIV WT and Eps8 KO primary hippocampal
cultures.
Three micromolar ifenprodil, a concentration which does
not affect GluN2A-containing receptors (Tovar and Westbrook,
1999), blocked ∼40% of the synaptic NMDA-mediated mEPSCs
in Eps8 KO neurons vs. ∼10% in WT neurons (Hz, WT
ctrl: 2.130 ± 0.15, n = 8 cells, WT + ifenprodil: 1.99 ± 0.18
n = 9 cells; EPS8 KO Ctrl: 1.432 ± 0.11 n = 12 cells,
EPS8 KO + ifenprodil: 1.044 ± 0.127, n = 9 cells; pA: WT
Ctrl: 8.4 ± 0.3, WT + ifenprodil: 7.675 ± 0.6; EPS8 KO
Ctrl: 10.8 ± 0.78, EPS8 KO + ifenprodil: 7.0 ± 0.7 Mann
Whitney Test ∗P = 0.0270; Unpaired t-test ∗∗P = 0.0065;
Figures 2A–C) indicating that mature EPS8 KO primary
hippocampal cultures display an altered GluN2B/2A synaptic
composition. To further investigate the contribution of specific
receptor subtypes to NMDA currents in WT vs. Eps8 KO
neurons, we recorded the total current produced by fast local
application of saturating NMDA concentrations (200 µM,
5 s), which activate both synaptic and extrasynaptic NMDARs.
NMDA application produced large responses, with a comparable
amplitude between WT and EPS8 KO neurons (pA/pF: WT,
19.24 ± 1.5 n = 14 cells; EPS8 KO, 17.76 ± 2 n = 16 cells;
Unpaired t-test P = 0.6200; Figures 2D,E). However, mutant
neurons were more sensitive to the non-competitive GluN2B
blocker, as shown by the significantly larger inhibition of
NMDA-mediated total current in EPS8 KO hippocampal
neurons exposed to 3 µM ifenprodil with respect to WT
neurons (% ifenprodil inhibition: WT, 43.71 ± 6 n = 8 cells;
EPS8 KO, 61.8 ± 3 n = 8 cells, Mann Whitney Test
∗P = 0.0127; Figure 2F). This evidence is consistent with
a higher amount of GluN2B-containing receptors in mutant
neurons. Notably, exposure of WT and KO neurons to tricine
(10 mM), a chelator of Zn2+ ions which tonically inhibits
GluN2A-contaning NMDARs by binding to the Zn2+ binding
site on the GluN2A subunits (Paoletti et al., 1997), resulted
in enhanced NMDA responses at a significantly higher extent
in WT relative to KO neurons (Figure 2G; Mann Whitney
Test, ∗∗∗P < 0.001 and ∗P = 0.0220). These data reveal a
reduced GluN2A- and an increased GluN2B-component of
NMDAR activity in Eps8 KO hippocampal neurons with respect
to age-matched WT primary hippocampal cultures suggesting
that the lack of Eps8 affects the process of NMDAR complex
maturation in neurons.
Since Eps8 regulates actin dynamics in filopodia and
spines, we aimed to assess whether the integrity of the actin
cytoskeleton affects the subunit composition of NMDARs.
To this aim, primary cultured hippocampal neurons were
treated with LatB (300 nM from 10 DIV to 14 DIV) to
depolymerize actin and disrupt its coupling to NMDARs during
synapse development in vitro (Allison et al., 1998; Sattler
et al., 1999). We then measured the total current produced
by fast local application of NMDA (200 µM, 5 s), before
and after bath application of ifenprodil (3 µM). Chronic
treatment with LatB does not affect the current density of
NMDA responses (pA/pF: vehicle, 23.34 ± 1.752 n = 18 cells;
LatB chronic, 24.71 ± 2.09 n = 17 cells; Unpaired t-test
P = 0.602; Figures 2H,I). However, LatB-treated cultures were
more sensitive to the GluN2B blocker, ifenprodil, as shown
by the increased percentage of inhibition of NMDA currents
(% ifenprodil inhibition: vehicle, 55.73 ± 4.5 n = 19 cells;
LatB chronic, 71.21 ± 1.9 n = 15 cells, Unpaired t-test
∗∗P = 0.0078; Figure 2J). Furthermore, we performed live
staining of LatB-or vehicle-treated hippocampal cultures with
antibodies directed against the extracellular epitopes of GluN2B.
Increased exposure of GluN2B-containing receptors at the
synaptic surface, identified by the presynaptic marker bassoon,
was detected upon LatB treatment (Figures 2K,L; synaptic
surface GluN2B: Vehicle = 1 ± 0.074 n = 13 fields;
LatB = 1.531 ± 0.073 n = 13 fields in at least three independent
experiments. Mann-Whitney Rank Sum Test, P ≤ 0.0001),
suggesting that the integrity of F-actin is required to set the
proper NMDAR composition at the synapse. The efficacy of
LatB (300 nM from 10 DIV to 14 DIV) in inducing F-actin
depletion in neuronal processes was assessed by Phalloidin
staining (Supplementary Figure S2). These data indicate that
actin depolymerization, similarly to Eps8 genetic depletion,
results in enhanced exposure of GluN2B-containing receptors at
the synaptic surface.
The role of Eps8 in regulating the NMDA receptor
subunit composition at synapses was also examined by
Western blotting (WB) analysis in homogenates and
postsynaptic TIF (Gardoni et al., 2001a, 2009) prepared
from hippocampi of adult WT or Eps8 KO mice (5 months
of age). At first, we confirmed that TIF sample was
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FIGURE 3 | Increased levels of GluN2B-containing and Y1472-GluN2B phosphorylated NMDARs in synaptic triton insoluble fraction (TIF) from Eps8 KO tissue.
(A) Western blotting (WB) analysis confirmed that TIF preparation was actually enriched in postsynaptic proteins. (B–D) WB analysis and relative quantification in
homogenate and TIF fractions for the indicated antibodies. All the WB were run twice (data are mean ± SEM, N = 4; Kruskal-Wallis test followed by Dunn’s multiple
Comparison test ∗P < 0.05, ∗∗P < 0.01).
actually enriched in postsynaptic proteins. As shown in
Figure 3A, the protein levels of the GluN2A-subunit of
NMDAR and of the postsynaptic scaffold protein, PSD-95,
were strongly higher in TIF fraction compared to the total
homogenate.
No difference in the expression levels of any tested NMDAR
subunit was found in the homogenate prepared from hippocampi
of Eps8 KO compared to WT adult mice (Figures 3B,C).
Conversely, profound differences in NMDAR composition were
detected in the postsynaptic compartment as indicated by
the immunoblot and relative quantification of TIF fraction
(Figures 3B,D). In line with electrophysiological data reported
in Figures 2A–G, Eps8 KO tissue was characterized by a
significantly higher GluN2B content in the synaptic TIF fraction
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison
test ∗∗P < 0.01, n = 4) in the absence of any significant alteration
in the GluN2A subunit (Figures 3B,D).
Previous studies reported that direct phosphorylation
of the GluN2B subunit by tyrosine kinases in a specific
phospho-site is crucial for the dynamic regulation of GluN2B
trafficking/turnover (Dunah and Standaert, 2001). Of relevance,
GluN2B phosphorylation is mainly restricted to a synaptic
fraction (Dunah et al., 2000; Gardoni et al., 2006). We
therefore monitored GluN2B Tyr phosphorylation using
phospho-specific antibodies raised against the Tyr1472
phospho-site in the C-terminal domain of the receptor
subunit (Y1472-GluN2B site). Interestingly, the staining
pattern produced in TIF fractions by the GluN2B phospho-
specific antibody paralleled the altered level of total GluN2B
(Figures 3B–D), thus indicating a significant increase of
the GluN2B phosphorylated form in Eps8 KO hippocampal
neurons compared to WT (Kruskal-Wallis test followed
by Dunn’s Multiple Comparison test ∗P < 0.05 4, n = 4).
Furthermore GluN2B Y1472 phosphorylation disrupts the
binding to the AP-2 clathrin-associated adaptor protein
complex, which targets proteins for endocytosis (Lavezzari
et al., 2003). Therefore, an increase in Y1472 GluN2B
phosphorylation levels may be linked to decreased GluN2B
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FIGURE 4 | Eps8 KO neurons display an increased NMDA-mediated tonic inward noisy current. (A) Examples of NMDA-only mEPSCs/“noise” recorded in [0 Mg2+]e
ACSF which is abolished by perfusion with the NMDAR antagonist, APV. Dashed lines indicate extrapolated pre-APV shift in holding current. (B) Summary of the shift
of holding current as a result of 50 µM APV application. (C,D) AP-5-associated change in a baseline noise. Quantification of background noise was obtained plotting
all values of recordings traces and comparing the fluctuation of values distribution. Data are mean ± SEM (Mann Whitney test, ∗∗P < 0.01).
endocytosis, thus representing a possible mechanism underlying
the increase of GluN2B-containing NMDARs in Eps8 KO
synapses.
To assess whether the increase of GluN2B-containing
receptors is restricted only at synaptic regions, we evaluated the
levels of phosphorylated ERK1/2 in hippocampi of mutant adult
mice relative to WT. Indeed, it has been shown that synaptic
NMDARs promote ERK phosphorylation, whereas extrasynaptic
NMDARs lead to ERK dephosphorylation and subsequent
inactivation (Hardingham and Bading, 2010). As shown in
Figures 3B,C, no increase of phosphorylated ERK1/2 levels
(Kruskal-Wallis test followed by Dunn’s Multiple Comparison
test, n = 4) occurred in Eps8 KO homogenate. This result
suggests that the ratio of synaptic vs. extrasynaptic GluN2B-
containing NMDARs is not changed probably due to an increase
GluN2B-containing NMDARs also at the extrasynaptic level.
To further investigate this issue we measured the tonic inward
noisy current in [0 Mg2+]e and 20 µM CNQX, which has been
demonstrated to involve extrasynaptic NMDARs activation in
cortical pyramidal neurons (LoTurco et al., 1990; Gottesman
and Miller, 2003; Povysheva and Johnson, 2012), possibly due
to ambient glutamate or glutamate spillover (Sah et al., 1989;
Cavelier et al., 2005; Le Meur et al., 2007). Recordings of
NMDA-mediated mEPSCs in [0 Mg2+]e at −70 mV from
EPS8 KO primary hippocampal neurons displayed a higher
noisy signal than WT (Figures 4A,B). Bath application of
the NMDAR blocker, APV (50 µM), to WT and EPS8 KO
primary cultures reduced noise and abolished the tonic inward
current (Figures 4A,B). Moreover, Eps8 KO hippocampal
neurons display enhanced background noise respect to WT,
measured as the variance of the change of baseline noise
at −70 mV before and after bath application of ifenprodil
(3 µM; Unpaired t-test ∗∗P = 0.0044; Figures 4C,D). These
data suggest that Eps8 KO neurons display increased content of
GluN2B-containing receptors at both synaptic and extrasynaptic
sites.
All together these data demonstrate that Eps8 KO
hippocampal neurons display altered expression of GluN2A-
and GluN2B-containing NMDARs and indicate that mutant
neurons show a significantly higher amount of both synaptic and
extrasynaptic GluN2B-containing NMDARs.
DISCUSSION
At the synaptic level, the process of actin remodeling is tightly
regulated by a plethora of actin regulating proteins (Sekino
et al., 2007; Hotulainen and Hoogenraad, 2010; Bertling and
Hotulainen, 2017); among them the actin capping protein, Eps8,
is a key factor for dendritic spine morphogenesis (Menna et al.,
2013; Stamatakou et al., 2013), and interfering with the capping
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activity of Eps8 or the genetic elimination of Eps8—such as in
Eps8 null neurons—prevents the ability of neurons to undergo
NMDA-dependent long term potentiation (Menna et al., 2013).
Besides controlling F-actin, Eps8 has been also shown to be
part of the NMDAR complex (Offenhauser et al., 2006). In this
study, we demonstrate that the lack of Eps8 results in altered
subunit composition of synaptic NMDARs, with higher synaptic
levels of functional GluN2B- and lower amount of GluN2A-
containing receptors. These results indicate that Eps8 is required
not only for the process of spine morphogenesis but also for
the proper functional maturation of excitatory synapses. The
possibility that an abnormal regulation of actin dynamics might
be at the origin of the altered maturation of synaptic NMDAR
complex in Eps8 KO primary hippocampal neurons is suggested
by our results indicating that chronic treatment with LatB results
in a similar enhancement in the surface exposure of GluN2B
subunits. Consistently, perturbing actin polymerization was
previously shown to result in altered NMDA-mediated currents
in neurons (Rosenmund and Westbrook, 1993). Previous study
have reported that mice overexpressing GluN2B subunit exhibit
enhanced hippocampal LTP, prolonged NMDAR currents, and
improved memory (Tang et al., 1999) which is maintained also
during aging (Cao et al., 2007) suggesting that increasing GluN2B
subunit might be beneficial for learning and memory processes.
However we previously showed that Eps8 KO neurons are not
able to undergo LTP in vitro and are characterized by cognitive
defects in vivo (Menna et al., 2013) that are primarily due to
the loss of the capping activity of the protein as they were fully
recapitulated in vitro by acute inhibition of Eps8 capping activity
inWT neurons by using a specific blocking peptide (Menna et al.,
2013).
In line with the interaction of Eps8 with NMDAR subunits
(Offenhauser et al., 2006), our data indicate a specific defect
in NMDAR function in mutant neurons. Although we cannot
exclude that additional glutamatergic components may be
affected by Eps8 lack, no major defects in AMPA-type
glutamate receptor trafficking and composition were detected
in Eps8 KO neurons. Indeed, Eps8 KO hippocampal cultures,
similarly to wt, were able to undergo homeostatic plasticity in
response to neuronal network silencing, a form of Hebbian
plasticity requiring AMPAR insertion at the synapse, in a
NMDA-independent manner (Wierenga et al., 2006; Turrigiano,
2008; see also Supplementary Figures S1A,B). Also, no changes
were detected in the rectification index of Eps8 KO cultures,
a value indicative of the presence of different AMPAR subunit
subtypes at postsynaptic sites (Hollmann et al., 1991; Derkach
et al., 2007; see Supplementary Figures S1C,D).
Numerous studies have demonstrated that the maturation of
brain circuitries is usually coincident with the NMDAR subunit
switch (e.g., GluN2B-to-GluN2A and GluN3A-to-GluN3B) that
occurs at the onset of the critical period of development
(Williams et al., 1993; Monyer et al., 1994; Sheng et al.,
1994; Paoletti and Neyton, 2007). The NMDAR subunit shift,
which therefore marks the transition from immature to mature
neural processing (Dumas, 2005), makes the NMDARs extremely
vulnerable to genetic and environmental risk factors (Spear,
2000). Of note, the regulation of GluN2A\GluN2B expression
and subunit assembly into functional NMDARs is altered in a
number of neurological disorders that are characterized also by
cognitive defects.
For example, NMDAR hypofunction has been reported in
mouse models of schizophrenia (Mohn et al., 1999), increased
GluN2B surface expression is observed in Huntington’s disease
(Fan and Raymond, 2007; Milnerwood et al., 2010) and genetic
evidence clearly implicates association of autism with the NMDA
receptor subunit GluN2B (Tarabeux et al., 2011; Yoo et al.,
2012). Interestingly, our data show that Eps8 KO adult mice are
characterized by an increase in the membrane levels of GluN2B-
containing NMDARs (both at the synaptic and extrasynaptic
sites), in absence of significant changes in total expression.
Notably, this event is mediated by an increase in GluN2B
Y1472 phosphorylation that decreases the GluN2B subunit
endocytosis.
From our data the possibility therefore emerges that Eps8 is
a central element in the proper maturation of postsynaptic
excitatory compartment, since the developmental switch from
GluN2B-type to GluN2A-type NMDARs is absent or disturbed
in Eps8 KO mice. By controlling the actin cytoskeleton,
Eps8 orchestrates the structural spine platform (Menna et al.,
2013), and the NMDARs function (Offenhauser et al., 2006), and
this study), thus linking morphological and functional changes
of dendritic spines during development or plasticity phenomena,
both in physiological and pathological conditions.
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FIGURE S1 | (A) Examples of whole-cell patch clamp recordings of mEPSCs
from WT and KO hippocampal neurons treated or not with TTX (1 µM) for 48 h to
induce homeostatic plasticity. (B) Quantitation of mEPSC amplitude in control and
TTX conditions showing that both WT and KO neurons were able to undergo
homeostatic potentiation (WT ctrl, pA: 22.25 ± 0.7 n = 8 cells, WT TTX:
35.45 ± 5 n = 10 cells; Mann Whitney test ∗P = 0.022; KO ctrl: 22.96 ± 1.9
n = 12 cells, KO TTX: 30.4 ± 2.8 14 cells; Unpaired t-test, ∗P = 0.044).
(C) Example of AMPA-mediated EPSCs recorded at +40 mV and at −60 mV in
WT (top) and EPS8 KO neurons (bottom). (D) Summary bar graphs of rectification
index analysis (RI: amplitude response at 40 mV/amplitude response at −60 mV)
showing no difference in RI value between the two genotypes. All data shown
represent the mean±SEM (Mann Whitney test P = 0.5501).
FIGURE S2 | Representative images of primary hippocampal neurons treated or
not with LatrunculinB (300 nM from 10 DIV to 14 DIV). At 14 DIV neurons were
fixed and stained for the postsynaptic markers PSD-95 (green) and for actin
filaments by using the specific compound phalloidin. Scale bar depicts 10 µm.
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